Arrhythmogenic right ventricular cardiomyopathy

New England Journal of Medicine

Volumn 376, Issue 15, 2017, Pages 1489-1490

  Corrado, Domenico ^a   Link, Mark S ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPLAKIN;

ANCESTRY GROUP; DEFIBRILLATION; DSP GENE; ENGLISHMAN; GENE; GENE EXPRESSION; GENE MUTATION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LETTER; MISSENSE MUTATION; NEWFOUNDLAND AND LABRADOR; PHENOTYPE; RISK FACTOR; SUDDEN CARDIAC DEATH; TMEM43 GENE; UNITED KINGDOM; ELECTROCARDIOGRAPHY;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS;

EID: 85018465533     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1701400     Document Type: Letter

References (4)

1. Rigato I, Bauce B, Rampazzo A, et al. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet 2013; 6: 533-42.
2. Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an International Task Force consensus statement. Circulation 2015; 132: 441-53.
3. Hodgkinson KA, Howes AJ, Boland P, et al. Long-term clinical outcome of arrhythmogenic right ventricular cardiomyopathy in individuals with a p.S358L mutation in TMEM43 following implantable cardioverter defibrillator therapy. Circ Arrhythm Electrophysiol 2016; 9(9): e003589.
4. Haywood AF, Merner ND, Hodgkinson KA, et al. Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada. Eur Heart J 2013; 34: 1002-11.